Well, I am the one the originally said 10 by X-mas. Well I am back, and still standing strong. I would say 8 next week. The market hurt this stock, but not much. I like it.
Note to x:
Don't bother talking to me, as I am ignoring you completely and totaly, unless you have something positive to contribute. If there really was something to the dilution, the investors would have known it. And MSON as a case in point? That's not a comparison. For one they had lower sales this qtr. Anyway. I know a lot of companies that had a lot more shares, but used those shares for accretive effects. That's the whole point here, and I think you have failed to realize it. I am not here to fight. I could care less how many shares there are. I am an investor in quality stocks that are growing, regardless of if they are issuing shares. Shares are not a problem. And chances are, if there is indeed 7 million in profit, then it will be accretive. And yes there are new contracts from Klevin and Concepts, so they will grow even without the new acquistion. As to earnings, they have to be out soon, like nine days, unless they file an extension. So I am on and ready for a move. |
